|
ITPR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
8.332800E-01 |
| Stage1-vs-Stage2 |
3.988200E-01 |
| Stage1-vs-Stage3 |
6.077600E-01 |
| Stage1-vs-Stage4 |
3.606600E-01 |
| Stage2-vs-Stage3 |
8.120000E-01 |
| Stage2-vs-Stage4 |
3.298600E-01 |
| Stage3-vs-Stage4 |
3.405400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.88479998275426E-09 |
| Caucasian-vs-AfricanAmerican |
4.306600E-01 |
| Caucasian-vs-Asian |
6.862600E-01 |
| AfricanAmerican-vs-Asian |
5.752800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
9.24590000117576E-08 |
| Male-vs-Female |
7.464000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.062600E-03 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
5.65129999999803E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.802960E-01 |
| Normal_Weight-vs-Obese |
3.074200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.472600E-01 |
| Extreme_Weight-vs-Obese |
2.256800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.156000E-01 |
| Obese-vs-Extreme_Obese |
8.025600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.29365440371521E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
<1E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.191400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.465800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.744100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.263200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.631600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.719950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.62436730732907E-12 |
| Normal-VS-KIRP CIMP |
9.160400E-01 |
| Normal-VS-Unclassified PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-Type2 PRCC |
4.957900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.242000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.425900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.816000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.259400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.683000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
<1E-12 |
| Normal-vs-N2 |
5.811000E-01 |
| N0-vs-N1 |
2.728400E-01 |
| N0-vs-N2 |
3.554000E-01 |
| N1-vs-N2 |
3.685000E-01 |
|
|
